Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience.

ABSTRACT:

Purpose

Pediatric oncology patients undergoing active chemotherapy are suspected to be at a high risk for severe disease secondary to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection; however, data to support this are lacking. We aim to describe the characteristics of coronavirus disease 2019 (COVID-19) in this population and also its impact on pediatric cancer care in the New York region during the peak of the pandemic.

Patients and methods

This multicenter, retrospective study included 13 institutions. Clinical and laboratory information on 98 patients ≤21 years of age receiving active anticancer therapy, who tested positive for SARS-CoV-2 by nasopharyngeal swab polymerase chain reaction (PCR), was collected.

Results

Of the 578 pediatric oncolo

SUBMITTER: Madhusoodhan PP 

PROVIDER: S-EPMC7883045 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature